Ligand Pharmaceuticals, Inc. (LGND)
199.69
+0.04
(+0.02%)
USD |
NASDAQ |
Apr 01, 16:00
199.95
+0.26
(+0.13%)
After-Hours: 20:00
Ligand Pharmaceuticals Research and Development Expense (TTM) : 81.18M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 135.84M |
| ADMA Biologics, Inc. | 4.761M |
| Intuitive Surgical, Inc. | 1.312B |
| Globus Medical, Inc. | 146.94M |
| Establishment Labs Holdings, Inc. | 20.25M |